Observational Study of Early Metabolic and Vascular Changes in Obesity

NCT00482924 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2021-09-22

No results posted yet for this study

Summary

To work against the increasing burden of obesity, the STYJOBS / EDECTA (STYrian Juvenile OBesity Study / Early DetECtion of Atherosclerosis) project was started at the Medical University of Graz in 2003. STYJOBS / EDECTA is a prospective, observational study to improve the understanding of atherosclerosis, cardiovascular risk, immune mediated low grade Inflammation, metabolic changes, and general disease propensity in obesity. The investigation of the "non-biased" early phase is strongly focused.

Based on this information, new and effective strategies for preclinical diagnostics and early intervention are of main interest. We seek a better understanding of critical lipid profiles, chronic immune-mediated inflammation, disturbed adipokine balance, critical adipose tissue topography, addiction like behaviour, genetics/epigenetics, early vascular pathology, and fatty liver disease. Interventional branches of study tested a holistic strategy comprehending sports, and lifestyle modification for efficiency. The investigative spectrum of STYJOBS / EDECTA comprehends also non-obese body weight extremes i.e. underweight/anorectic people.

Conditions

Interventions

OTHER

Lifestyle intervention

Regular sports and dietary advices. Controlled by analysis of laboratory parameters, BMI change and performance diagnostics. No drugs included so far.

Sponsors & Collaborators

  • Zukunftsfonds Steiermark

    collaborator OTHER
  • Bundesministerium für Gesundheit, Familie und Jugend

    collaborator UNKNOWN
  • Steiermärkische Landesregierung

    collaborator UNKNOWN
  • Graz University of Technology

    collaborator OTHER
  • University of Graz

    collaborator OTHER
  • Paracelsus Medical University

    collaborator OTHER
  • Technical University of Munich

    collaborator OTHER
  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Harald Mangge, Prof., MD · Medical University of Graz, Austria

Eligibility

Min Age
3 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00482924 on ClinicalTrials.gov